Symposium B2
Drug targeting: principles and products for precision medicine

Tuesday 23 May 2017
08:00-11:00
Stockholmsmässan : K2

Introduction

Many drug delivery systems and drug targeting strategies have been evaluated over the years. In this session, recent advances in the use of targeted (nano-) therapeutics for improving the treatment of cancer, cardiovascular disease and inflammatory disorders will be presented. In this context, both fundamental insights into biological and pathophysiological mechanisms, as well as progress towards pharmaceutical production and clinical translation will be addressed.

Chair: Twan Lammers (Germany)

Programme

08:00 – 08:10 Introductory remarks
Twan Lammers, RWTH Aachen University Clinic, Germany

08:10 – 08:45 Drug targeting to tumors: Concepts and barriers vs. ever more nanocarriers
Twan Lammers, RWTH Aachen University Clinic, Germany

08:45 – 09:20 Harnessing RNA nanomedicine for Precision therapy in cancer and inflammation
Dan Peer, Tel Aviv University, Israel

09:20 – 09:40 BREAK

09:40 – 10:15 Drug targeting and imaging in cardiovascular disease
Willem Mulder, Mount Sinai School of Medicine, USA

10:10 – 10:50 Bioresponsive polymeric nanomedicines for tumor targeting
Zhiyuan Zhong, Soochow University, China

10:50 – 11:00 Concluding remarks
Twan Lammers, RWTH Aachen University Clinic, Germany